ARTELO BIOSCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
ARTELO BIOSCIENCES, INC. (ARTL) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $0.63 per share for the 4-month period ending 2021-12-31, per its 10-KT filed 2022-03-21.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2022-03-21
- ARTELO BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2020-11-30 was $0.60.
- ARTELO BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2019-11-30 was $0.00.
- ARTELO BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2021 was $2.28, a 8.06% decline from fiscal 2020.
- ARTELO BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2020 was $2.48, a 23.38% increase from fiscal 2019.
- ARTELO BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2019 was $2.01, a 81.39% decline from fiscal 2018.
- ARTELO BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2018 was $10.80.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 4 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|---|
| 2021-12-31 | $0.63 10-KT · filed 2022-03-21 | ||||
| 2021-08-31 | $2.28 10-KT · filed 2022-03-21 | ||||
| 2021-05-31 | $2.31 10-Q · filed 2021-07-12 | ||||
| 2021-02-28 | $2.54 10-Q · filed 2021-04-13 | ||||
| 2020-11-30 | $0.60 10-Q · filed 2021-01-14 | ||||
| 2020-08-31 | $2.48 10-KT · filed 2022-03-21 | ||||
| 2020-05-31 | $2.48 10-Q · filed 2020-07-13 | ||||
| 2020-02-29 | $2.48 10-Q · filed 2020-04-13 | ||||
| 2019-11-30 | $0.00 10-Q · filed 2020-01-14 | ||||
| 2019-08-31 | $2.01 10-K · filed 2020-11-04 | ||||
| 2019-05-31 | $0.00 10-Q · filed 2019-07-15 | ||||
| 2019-02-28 | $0.00 10-Q · filed 2019-04-15 | ||||
| 2018-08-31 | $10.80 10-K/A · filed 2019-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |